Pulmonary Drug
Delivery Devices Market Size, Market Share, Application Analysis, Regional
Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017
To 2025
Pulmonary Drug
Delivery Devices Market - Growth, Share, Opportunities, Competitive Analysis,
and Forecast, 2017 - 2025, the Pulmonary Drug Delivery Devices market was
valued at USD 134.6 Bn in 2016, and is expected to reach USD 218.6 Bn by 2025,
expanding at a CAGR of 5.4% from 2017 to 2025.
View Full Report with TOC @ http://www.acutemarketreports.com/report/pulmonary-drug-delivery-devices-market
Market Insights
Increasing demand
for noninvasive drug administration for respiratory diseases through pulmonary
route is expected to boost the market of such devices. According to market
experts the efficiency of pulmonary drug delivery devices is high because lungs
possess ability to provide large absorptive surface area (up to 100 m2 ) but
extremely thin (0.1 µm – 0.2 µm) absorptive mucosal membrane and ample blood
supply. Recent advances have developed the overall technology and formulation
for pulmonary drug delivery devices. However, pulmonary delivery of peptides
and proteins is still complicated due to the anatomic structure of human
respiratory system and the effect of nature applied by the respiration process.
The key factors responsible for growth of pulmonary drug delivery devices are
rising prevalence of respiratory diseases, increasing air pollution in
developed and developing countries, high public awareness associated with early
diagnosis of respiratory diseases, and incessant research and development activities
in the field of drug delivery.
In year 2016,
metered dose inhalers accounted for the largest market share in pulmonary drug
devices market due to key drivers rising prevalence of asthma and COPD across
the globe, high patient convenience, the products and technology has penetrated
in market over these years, and observed as the most preferred technology by
physicians. During the forecast period 2017 – 2025, dry powder inhalers were
anticipated as the fastest growing segment due to key driving factors such as
short administration and preparation time, fewer irritant effects and control
of inhaled dose, and API protection. A few major brands available in dry powder
inhalers category are Spiriva, Atrovent, Foradil, Rotahaler, and FlowCaps among
others.
View Full Report with TOC @ http://www.acutemarketreports.com/report/pulmonary-drug-delivery-devices-market
The major
application of pulmonary drug delivery devices is into asthma and COPD, in year
2016 asthma accounted for the largest market share due to rising prevalence of
asthma, most preferred mode of treatment in asthma, and increasing public
awareness related to respiratory diseases. According to World Health Organization
(WHO), it is estimated that approximately 334 million people currently suffer
from asthma, and 250,000 deaths are attributed to the disease each year. The
prevalence of the disease is continuing to grow, and the overall prevalence is
estimated to increase by 100 million by 2025. Thus, asthma segment is expected
to grow during the forecast period 2017 – 2025 and ultimately assist the growth
of overall pulmonary drug delivery devices market.
North America was
observed as the largest pulmonary drug delivery devices market due to rising
prevalence of respiratory diseases, trending patients and physicians
preferences for user friendly drug delivery devices, and increasing demand for
fast acting & efficient drug delivery technology. The overall developed
healthcare infrastructure, high patient awareness associated with respiratory
disease management, and incessant research and development activities in the
field of pulmonary drug delivery industry. During forecast 2017 – 2025, Asia
Pacific was observed as the fastest growing market segment due to developing
healthcare infrastructure, mounting economic growth is fueling air pollution,
high public awareness related to respiratory diseases and hygiene, and
increasing disposable income.
Market Competition Assessment:
The pulmonary drug
delivery devices market is observed as the most diversified and competitive
market comprising large number of players. The market is dominated by several
players, depending on their major competencies. The key players in this market
are GlaxoSmithKline, Boehringer Ingelheim GmbH, 3M, AstraZeneca plc, Merck
& Co., Inc., Novartis AG, Omron Corporation and Sunovion Pharmaceuticals
Inc. among others.
Key Market Movements:
- Rising prevalence
of respiratory diseases especially asthma and COPD
- Increasing industrialization and economic growth is fuelling the air pollution causing rise in asthma and COPD
- User friendly, fast acting and cost efficient pulmonary drug delivery devices are in demand
- Increasing industrialization and economic growth is fuelling the air pollution causing rise in asthma and COPD
- User friendly, fast acting and cost efficient pulmonary drug delivery devices are in demand
Download Free Sample Report @ http://www.acutemarketreports.com/request-free-sample/108985
About Us:
Acute Market Reports
is the most sufficient collection of market intelligence services online. It is
your only source that can fulfill all your market research requirements. We
provide online reports from over 100 best publishers and upgrade our collection
regularly to offer you direct online access to the world’s most comprehensive
and recent database with expert perceptions on worldwide industries, products,
establishments and trends. Our database consists of 200,000+ market research
reports with detailed & minute market research.
Contact info:
Name: Chris Paul
Designation: Global Sales Manager
Email: sales@acutemarketreports.com
Ph: +1-855-455-8662
No comments:
Post a Comment